1. Home
  2. ARCT vs MLP Comparison

ARCT vs MLP Comparison

Compare ARCT & MLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • MLP
  • Stock Information
  • Founded
  • ARCT 2013
  • MLP 1909
  • Country
  • ARCT United States
  • MLP United States
  • Employees
  • ARCT N/A
  • MLP N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • MLP Real Estate
  • Sector
  • ARCT Health Care
  • MLP Finance
  • Exchange
  • ARCT Nasdaq
  • MLP Nasdaq
  • Market Cap
  • ARCT 298.3M
  • MLP 295.0M
  • IPO Year
  • ARCT N/A
  • MLP 1972
  • Fundamental
  • Price
  • ARCT $11.86
  • MLP $14.74
  • Analyst Decision
  • ARCT Strong Buy
  • MLP
  • Analyst Count
  • ARCT 7
  • MLP 0
  • Target Price
  • ARCT $57.40
  • MLP N/A
  • AVG Volume (30 Days)
  • ARCT 410.5K
  • MLP 20.6K
  • Earning Date
  • ARCT 05-12-2025
  • MLP 05-23-2025
  • Dividend Yield
  • ARCT N/A
  • MLP N/A
  • EPS Growth
  • ARCT N/A
  • MLP N/A
  • EPS
  • ARCT N/A
  • MLP N/A
  • Revenue
  • ARCT $143,680,000.00
  • MLP $11,565,000.00
  • Revenue This Year
  • ARCT N/A
  • MLP N/A
  • Revenue Next Year
  • ARCT $44.93
  • MLP N/A
  • P/E Ratio
  • ARCT N/A
  • MLP N/A
  • Revenue Growth
  • ARCT 15.38
  • MLP 24.50
  • 52 Week Low
  • ARCT $8.04
  • MLP $14.05
  • 52 Week High
  • ARCT $45.00
  • MLP $26.46
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 50.74
  • MLP 40.89
  • Support Level
  • ARCT $10.70
  • MLP $14.52
  • Resistance Level
  • ARCT $13.10
  • MLP $15.45
  • Average True Range (ATR)
  • ARCT 0.89
  • MLP 0.64
  • MACD
  • ARCT -0.01
  • MLP 0.05
  • Stochastic Oscillator
  • ARCT 35.69
  • MLP 10.53

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About MLP Maui Land & Pineapple Company Inc.

Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales which includes land planning and entitlement, development, and sales activities; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.

Share on Social Networks: